Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Thursday, April 19, 2018 · 442,944,776 Articles · 3+ Million Readers

Global Interventional Cardiology Surgery, Devices and Drugs Market Research and Forecast, 2018-2023

Global cardiology surgery devices drugs market, Size, Share, Intelligence, Company Profiles, Trends, Strategy, Research Report, Analysis, Forecast 2018-2023

Rising incidences of cardiovascular diseases have been propelling the market growth”
— OMR Analyst

INDORE, INDIA, March 12, 2018 /EINPresswire.com/ -- Orion Market Research (OMR), recently published a market research report on global Cardiology Surgery, Devices and Drugs market. According to the OMR analysis, the global Cardiology Surgery, Devices and Drugs market is expected to grow at a CAGR of 7.4% during 2018-2023. The global Interventional Cardiology market is segmented on the basis of device type, drug type, by mechanism and by surgery types. Major players contributing to the growth of Global Interventional Cardiology market includes Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific Corp., Medtronic, Jude Medical, Cook Medical, and CR Bard. Growing incidence of cardiovascular diseases and rising healthcare expenditure across the globe are driving the market. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Full report of Global Cardiology Surgery, Devices and Drugs Market is available at https://www.omrglobal.com/industry-reports/cardiology-surgery-devices-drugs-market/

Factors that are driving the global Cardiology Surgery, Devices and Drugs market are growing incidence of cardiovascular diseases, medical tourism in emerging market, and innovation and development in cardiovascular devices. Other key factors include availability of remote monitoring solutions and rising healthcare expenditure. Emerging APAC region will be full of opportunity for global Cardiology Surgery, Devices and Drugs market. There are wide variety of new procedures, drugs, and technologies to treat ailments that can affect the health and function of the human heart. One of the most significant advances in cardiac therapies is the use of cardiac catheters to give clinicians direct cardiac access, or access to the inside of the beating heart, via the vascular system. Innovation in technology is persistent with catheters, new developments including leadless pacemaker deployment, repairing holes in the heart with the aid of biodegradable adhesives and filtering out dangerous blood clots have developed. Although small, catheters are driving medical revolutions that reach into every corner of the human body.

The alternative to catheterization is open-heart intervention, an invasive procedure where the chest is opened to expose and stop the heart while the blood is artificially oxygenated and pumped throughout the body using a cardiopulmonary bypass machine. In addition to the significant post-operative recovery time from an open-chest procedure, CPB has the additional risks of stroke and long-term cognitive deficiencies for the patient. Cardiac catheters are the only clinically available technology that enables beating heart diagnosis and treatment inside the heart without the use of highly invasive open heart surgical techniques. This is popularizing interventional cardiology augmenting the market.

The global Cardiology Surgery, Devices and Drugs market by geography is segmented into North America, Europe, APAC, and Rest of the World. North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.9%. The pivotal factors contributing in the modest growth includes rise in the incidence and prevalence rate of cardiovascular diseases and technological advancement. The American Heart association in 2011 predicted that by 2030, upwards of 40 percent of the U.S. population that is more than 100 million Americans – would be suffering from some form of cardiovascular disease. However, the benchmark has been reached in 2015. The growing incidence is raising demand for cardiology drugs and devices. In 2015, 41.5 %(102.7 million) of the US population had at least one CVD condition: High Blood Pressure (96.1 million) Coronary Heart Disease (16.8 million), Stroke (7.5 million) Congestive Heart Failure (5.8 million) Atrial fibrillation (5.2 million). In order to overcome cardiovascular diseases, smartphones apps, wearables, health kiosks have been developed in the region. Additionally, robots, nanobots are also FDA approved for use in cardiology procedures. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2018-2023. APAC market is growing due to increasing healthcare expenditure, rising geriatric population and growing market for drug development.

Company profiled in the report
• Pfizer
• Sanofi S.A.
• AstraZeneca
• Novartis
• Bristol-Myers Squibb
• Merck
• Boston Scientific Corp.
• Medtronic
• St. Jude Medical
• Cook Medical
• CR Bard Inc.
• Sun pharma
• GE healthcare
• Johnson and Johnson
• Takeda pharmaceutical company Ltd
• Daiichi Sankyo co. Ltd.
• F. Hoffmann-la Roche Ltd
• Bayer AG
• Boehringer Ingelheim
• Otsuka

For related reports please visit
https://www.omrglobal.com/reports-category/pharmaceuticals/
https://www.omrglobal.com/reports-category/medical-devices/

The report covers:
• Comprehensive research methodology of Cardiology Surgery, Devices and Drugs market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global Cardiology Surgery, Devices and Drugs market
• Insights about market determinants which are stimulating the global Cardiology Surgery, Devices and Drugs market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. The company provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here

Powered by EIN Presswire